Outcomes of first-line (1L) ipilimumab and nivolumab (IPI-NIVO) and subsequent therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).

被引：1
|
作者：
Gan, Chun Loo
Wells, J. Connor
Schmidt, Andrew Lachlan
Powles, Thomas
Tran, Ben
Meza, Luis A.
Labaki, Chris
Lee, Jae-Lyun
Wood, Lori
Shapiro, Julia
Ernst, D. Scott
Kapoor, Anil
Canil, Christina M.
Yuasa, Takeshi
McKay, Rana R.
Beuselinck, Benoit
Donskov, Frede
Dudani, Shaan
Choueiri, Toni K.
Heng, Daniel Yick Chin
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] Univ Calgary, Calgary, AB, Canada
[3] Cairns & Hinterland Hosp & Hlth Serv, Liz Plummer Canc Ctr, Cairns, Qld, Australia
[4] Queen Mary Univ London, Royal Free Natl Hlth Serv Trust, Canc Res UK Expt Canc Med Ctr, Barts Canc Inst, London, England
[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[6] City Hope Comprehens Canc Ctr, Duarte, CA USA
[7] Dana Farber Canc Inst Individuals, Boston, MA USA
[8] Asan Med Ctr, Seoul, South Korea
[9] Univ Ulsan, Coll Med, Seoul, South Korea
[10] Dalhousie Univ, Halifax, NS, Canada
[11] Cabrini Hlth, Melbourne, Vic, Australia
[12] London Hlth Sci Ctr, London Reg Canc Program, Dept Oncol, Div Med Oncol, London, ON, Canada
[13] Univ Western Ontario, London, ON, Canada
[14] St Josephs Healthcare, McMaster Inst Urol, Hamilton, ON, Canada
[15] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada
[16] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[17] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[18] Univ Ziekenhuizen, Leuven Canc Inst, Leuven, Belgium
[19] Aarhus Univ Hosp, Aarhus, Denmark
[20] Univ Ottawa, Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[21] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4554
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).
    Schmidt, Andrew Lachlan
    Xie Wanling
    Gan, Chun Loo
    Wells, Connor
    Dudani, Shaan
    Donskov, Frede
    Porta, Camillo
    Suarez, Cristina
    Szabados, Bernadett
    Wood, Lori
    Ruiz Morales, Jose Manuel
    Tran, Ben
    Bjarnason, Georg A.
    Yuasa, Takeshi
    Beuselinck, Benoit
    Hansen, Aaron Richard
    Agarwal, Neeraj
    Bakouny, Ziad
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [42] Outcome of metastatic sarcomatoid renal cell carcinoma (sRCC): Results from the International mRCC Database Consortium
    Chittoria, Namita
    Zhu, Hui
    Choueiri, Toni K.
    Kroeger, Nils
    Lee, Jae-Lyun
    Srinivas, Sandy
    Knox, Jennifer
    Bjarnason, Georg A.
    MacKenzie, Mary J.
    Wood, Lori
    Vaishamayan, Ulka N.
    Agarwal, Neeraj
    Pal, Sumanta Kumar
    Tan, Min-Han
    Rha, Sun Young
    Yuasa, Takeshi
    Donskov, Frede
    North, Scott A.
    Rini, Brian I.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group
    Savard, Marie-France
    Wells, J. Connor
    Graham, Jeffrey
    Dudani, Shaan
    Steinharter, John A.
    McGregor, Bradley A.
    Donskov, Frede
    Bjarnason, Georg A.
    Vaishampayan, Ulka N.
    Hansen, Aaron R.
    Iafolla, Marco A. J.
    Zanotti, Giovanni
    Huynh, Lynn
    Chang, Rose
    Duh, Mei S.
    Heng, Daniel Y. C.
    ONCOLOGIST, 2020, 25 (05): : 422 - 430
  • [44] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC)-an International mRCC Database Consortium (IMDC) analysis
    Araujo, Daniel, V
    Wells, J. Connor
    Hansen, Aaron R.
    Dizman, Nazli
    Pal, Sumanta K.
    Beuselinck, Benoit
    Donskov, Frede
    Gan, Chun L.
    Yan, Flora
    Tran, Ben
    Kollmannsberger, Christian K.
    de Velasco, Guillermo
    Yuasa, Takeshi
    Reaume, M. Neil
    Ernst, D. Scott
    Powles, Thomas
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    Dudani, Shaan
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (05) : 820 - 826
  • [45] Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).
    Ernst, Matthew Scott
    Navani, Vishal
    Wells, J. Connor
    Donskov, Frede
    Basappa, Naveen S.
    Labaki, Chris
    Pal, Sumanta K.
    Meza, Luis A.
    Wood, Lori
    Ernst, D. Scott
    Szabados, Bernadett
    Mckay, Rana R.
    Parnis, Francis
    Suarez, Cristina
    Yuasa, Takeshi
    Kapoor, Anil
    Alva, Ajjai Shivaram
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [46] Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC)
    Takemura, K.
    Navani, V.
    Ernst, M. S.
    Wells, J. C.
    Choueiri, T. K.
    Meza, L.
    Pal, S. K.
    Lee, J-L.
    Li, H.
    Agarwal, N.
    Alva, A. S.
    Hansen, A. R.
    Basappa, N. S.
    Szabados, B. E.
    Powles, T. B.
    Tran, B.
    Hocking, C. M.
    Beuselinck, B.
    Yuasa, T.
    Heng, D. Y. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1209 - S1210
  • [47] Impact of bone and liver metastases (BM, LM) in patients with metastatic renal cell carcinoma (mRCC) treated with molecularly targeted agents (MTAs): Results from the International mRCC Database Consortium (IMDC)
    McKay, Rana R.
    Kroeger, Nils
    Xie, Wanling
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Bjarnason, Georg A.
    MacKenzie, Mary J.
    Wood, Lori
    Srinivas, Sandy
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Pal, Sumanta Kumar
    Donskov, Frede
    Tantravahi, Srinivas
    Rini, Brian I.
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [48] Predictors of progressive disease (PD) and subsequent outcomes in metastatic renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo)
    Zahoor, Haris
    Barata, Pedro C.
    Jia, Xuefei
    Hobbs, Brian P.
    Martin, Allison
    Allman, Kimberly D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC): An international mRCC database consortium (IMDC) analysis.
    Araujo, Daniel Vilarim
    Wells, Connor
    Hansen, Aaron Richard
    Dizman, Nazli
    Pal, Sumanta K.
    Beuselinck, Benoit
    Donskov, Frede
    Gan, Chun Loo
    Yan, Flora
    Tran, Ben
    Kollmannsberger, Christian K.
    de Velasco, Guillermo
    Yuasa, Takeshi
    Reaume, M. Neil
    Ernst, D. Scott
    Powles, Thomas
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Dudani, Shaan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Application of IMDC criteria across first-line (1L) and second-line (2L) therapies in metastatic renal-cell carcinoma (mRCC): New and updated benchmarks of clinical outcomes.
    Dudani, Shaan
    Gan, Chun Loo
    Wells, Connor
    Bakouny, Ziad
    Dizman, Nazli
    Pal, Sumanta K.
    Wood, Lori
    Kollmannsberger, Christian K.
    Szabados, Bernadett
    Powles, Thomas
    Beuselinck, Benoit
    Donskov, Frede
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Canil, Christina M.
    Srinivas, Sandy
    Agarwal, Neeraj
    Liow, Elizabeth Chien Hern
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345